Tags: acute pulmonary embolismpulmonary embolismanticoagulantbleedingprotamine
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | <em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. | Advances in Cancer Therapies and Diagnostics - 3 months ago | |
| 2 | Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA | ||
| 3 | Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. | Why bone marrow transplants are becoming less common - 4 months ago | |
| 4 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
| 5 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | ||
| 6 | Meghana Keshavan STAT News Biotech nerd and writer @statnews. | ||
| 7 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | ||
| 8 | Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California | ||
| 9 | Ian Ingram MedPage Today Deputy Managing Editor.
MedPage Today. New York, New York | FDA Approves Earlier Use of CAR-T Products for Myeloma - about 1 year ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - over 1 year ago | |
| 10 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma - about 1 year ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - about 1 year ago |